Asia-Pacific journal of clinical oncology · 2026
Contribution of Focal 1 8F-FDG Uptake on Positron Emission Tomography/Computed Tomography to Ultrasonography-Based Malignancy Risk Assessment in Incidentally Detected Thyroid Nodules.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Öztürk Yusuf, Kaya Buğra, Karadeniz Yusuf, Karaköse Melia
Аннотация
AIM: The present study sought to evaluate the incremental contribution of the presence of focal FDG uptake and SUVmax on PET/CT in predicting malignancy in incidentally detected thyroid nodules when assessed in conjunction with ultrasonography-based risk features.
METHODS: In this retrospective study, 304 incidentally detected thyroid nodules identified on PET/CT and confirmed by cytology and/or histopathology were analyzed. The clinical, ultrasonographic, and PET/CT findings were meticulously documented. The presence or absence of focal FDG uptake was subsequently visually assessed on PET/CT images, and SUVmax values were also calculated for FDG-avid nodules. The factors associated with malignancy were evaluated using univariate and multivariate logistic regression analyses.
RESULTS: The overall malignancy rate was 12.2%. The analysis revealed that focal FDG uptake was observed in 97.3% of malignant nodules and in 65.9% of benign nodules (p < 0.001). Among FDG-avid nodules, SUVmax values were significantly higher in malignant lesions (p < 0.001). However, in multivariate models incorporating ultrasonography-based risk features, focal FDG uptake demonstrated only borderline statistical significance (p = 0.055), while SUVmax was not independently associated with malignancy (p = 0.360).
CONCLUSION: The absence of focal FDG uptake on PET/CT was associated with a very low likelihood of malignancy in incidentally detected thyroid nodules. However, focal FDG uptake should be interpreted in conjunction with ultrasonography-based risk features rather than as an independent decision-making criterion. Although SUVmax values were higher in malignant FDG-avid nodules, SUVmax did not provide independent or additional diagnostic value beyond ultrasonography-based risk assessment.
METHODS: In this retrospective study, 304 incidentally detected thyroid nodules identified on PET/CT and confirmed by cytology and/or histopathology were analyzed. The clinical, ultrasonographic, and PET/CT findings were meticulously documented. The presence or absence of focal FDG uptake was subsequently visually assessed on PET/CT images, and SUVmax values were also calculated for FDG-avid nodules. The factors associated with malignancy were evaluated using univariate and multivariate logistic regression analyses.
RESULTS: The overall malignancy rate was 12.2%. The analysis revealed that focal FDG uptake was observed in 97.3% of malignant nodules and in 65.9% of benign nodules (p < 0.001). Among FDG-avid nodules, SUVmax values were significantly higher in malignant lesions (p < 0.001). However, in multivariate models incorporating ultrasonography-based risk features, focal FDG uptake demonstrated only borderline statistical significance (p = 0.055), while SUVmax was not independently associated with malignancy (p = 0.360).
CONCLUSION: The absence of focal FDG uptake on PET/CT was associated with a very low likelihood of malignancy in incidentally detected thyroid nodules. However, focal FDG uptake should be interpreted in conjunction with ultrasonography-based risk features rather than as an independent decision-making criterion. Although SUVmax values were higher in malignant FDG-avid nodules, SUVmax did not provide independent or additional diagnostic value beyond ultrasonography-based risk assessment.